Cerebral Toxoplasmosis — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Pyrimethamine + sulfadiazine + folinic acid
Cerebral toxoplasmosis in immunocompromised patients: pyrimethamine + sulfadiazine (or clindamycin) + folinic acid is the standard treatment. Duration is at least 6 weeks. Secondary prophylaxis is continued until immune reconstitution.
Reference: Therapeutic Guidelines – 2024 – Antibiotic: Toxoplasmosis